An announcement from Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) is now available.
Shanghai MicroPort MedBot (Group) Co., Ltd. has announced that its board of directors will hold a meeting on March 27, 2025, to discuss and approve the final results for the year ending December 31, 2024. The meeting will also consider the recommendation of a final dividend and address other business matters, which could impact the company’s financial strategy and shareholder returns.
More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
Shanghai MicroPort MedBot (Group) Co., Ltd. operates in the medical technology industry, focusing on the development and production of robotic medical devices. The company is based in China and is listed on the Hong Kong Stock Exchange.
YTD Price Performance: 115.04%
Average Trading Volume: 14,702,907
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$20.58B
Learn more about 2252 stock on TipRanks’ Stock Analysis page.